Jasvinder Gill
Jasvinder Gill publishes mostly in Endocrinology, Diabetes and Metabolism, Family Practice and Molecular Biology, on topics such as Diabetes Management and Research, Diabetes Treatment and Management and Hyperglycemia and glycemic control in critically ill and hospitalized patients.
- World rank
- #7,471,825 of 7,710,434 ranked researchers
- Rank in United States
- #1,611,156 of 1,627,098
- Works
- 50
- Citations
- 354
- Citations per work
- 7.1
What does Jasvinder Gill research?
Jasvinder Gill's work is mostly in Medicine (79%), Biochemistry, Genetics and Molecular Biology (6%), Economics, Econometrics and Finance (2%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences4079.5%
- Medicine4079.5%
- Everything else612.6%
- Life Sciences36.3%
- Social Sciences11.6%
- 1Endocrinology, Diabetes and Metabolism72% of their works
- 2Family Practice6% of their works
- 3Molecular Biology4% of their works
- 4Genetics2% of their works
- 5Economics and Econometrics2% of their works
- 6Physiology2% of their works
Research topics
- Diabetes Management and Research
- Diabetes Treatment and Management
- Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Medication Adherence and Compliance
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Diabetes and associated disorders
- Metabolism, Diabetes, and Cancer
- Diabetes Management and Education
Which keywords describe Jasvinder Gill's research?
The keywords of their largest research topics: Glycemic Control, Insulin Therapy, Diabetes, Cardiovascular Disease, Type 1 Diabetes, Continuous Glucose Monitoring, Hypoglycemia and Cardiovascular Outcomes.
- Metformin
- Depression
- AMP-Activated Protein Kinase
- Insulin Resistance
- Medication Adherence
- Critical Care
- Cardiovascular Outcomes
- Continuous Glucose Monitoring
- Cardiovascular Disease
- Insulin Therapy
- Glycemic Control
- Diabetes
- Type 1 Diabetes
- Hypoglycemia
- Type 2 Diabetes
- Hyperglycemia
- Treatment Adherence
- Metabolic Syndrome
- Autoimmunity
- Genetics
- Self-Management
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 21 words, with their numbers
- Glycemic Control844 topics
- Insulin Therapy813 topics
- Diabetes463 topics
- Cardiovascular Disease432 topics
- Type 1 Diabetes412 topics
- Continuous Glucose Monitoring381 topic
- Hypoglycemia381 topic
- Cardiovascular Outcomes321 topic
- Type 2 Diabetes321 topic
- Critical Care111 topic
- Hyperglycemia111 topic
- Medication Adherence71 topic
- Treatment Adherence71 topic
- Insulin Resistance51 topic
- Metabolic Syndrome51 topic
- AMP-Activated Protein Kinase31 topic
- Autoimmunity31 topic
- Depression31 topic
- Genetics31 topic
- Metformin31 topic
- Self-Management31 topic
Where does Jasvinder Gill work?
Jasvinder Gill's main affiliation in the publication record is Sanofi (United States), United States.
How many publications and citations does Jasvinder Gill have?
OpenAlex counts 50 works and 354 citations for Jasvinder Gill, an h-index of 12, ranking #7,471,825 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Jasvinder Gill. Posts are plain text and can be reported.